Please provide your email address to receive an email when new articles are posted on . In a study of patients with endometrial stromal sarcomas treated with aromatase inhibitors the objective ...

Recent advances in the biological and molecular understanding of rare uterine tumors have expanded therapeutic options for patients. Uterine cancers are a highly heterogeneous group of cancers that ...

A total of 53 patients with advanced non-GIST soft tissue sarcomas received sunitinib 37.5 mg daily. Primary end point was Response Evaluation Criteria in Solid Tumors defined response. Secondary end ...

About GIST and Other Soft-Tissue Sarcomas In The Abdomen Huntsman Cancer Institute’s Sarcoma Service has a specialist team that treats soft-tissue sarcomas that form in the abdomen. Here are some soft ...

Gastrointestinal stromal tumors (GISTs) are growths that form in the digestive tract. The overall GIST survival rate for 5 years is 85%. However, this rate cannot predict the survival of any ...

GDF15 and OPN show promise in differentiating uterine sarcoma from leiomyoma, outperforming traditional markers like LDH and CA125. GDF15 serves as an independent prognostic factor for ...